Project Grant K08NS138691

Award Date 8/10/24
Completion Date 7/31/29
Dollars Obligated $235K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Boston, MA 02114, USA
Similar Awards
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $481,250 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to President and Fellows of Harvard College. The grant's objective is to develop a synthetic biological system that can manipulate subcellular RNAs and proteins in a subtype- and context-specific manner within neurons. This system aims to enable novel investigations of how subcellular...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, will support research on the regulation of presynaptic gene transcripts during synaptogenesis. The $244,154 award, with a period of performance from September 1, 2024 to June 30, 2027, will be conducted by the Albert Einstein College of Medicine in Bronx, NY. The research aims...
This $632,243 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to understand the molecular and cellular mechanisms of cerebellar dysfunction in neurodevelopmental disorders (NDDs). The primary goal is to elucidate how disruptions to cerebellar inhibitory neurons, particularly Purkinje cells and GABAergic interneurons,...
This $242,310 Project Grant awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program supports research to investigate the effects of the NR2E1 genetic mutation on neurogenesis, neural stem cell biology, and associated behavioral outcomes. The research project aims to 1) assess how the I385T mutation in the NR2E1 gene impacts its ligand binding and...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $230,904 to support research aimed at identifying novel molecular genetic causes of infantile epilepsies and evaluating the clinical and family impact of genetic diagnoses. The grant recipient, The Children's Hospital Corporation (doing business as Boston Children's...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, will support research to understand the role of dysregulated eIF4E-mediated translational control in the pathogenesis of Focal Cortical Dysplasia Type II (FCDII). The $390,000 award will fund a 5-year project to investigate specific mRNA subsets affected by MNK-eIF4E signaling...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $404,340 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to the University of Georgia Research Foundation, Inc. The project aims to develop a novel method using split fluorescent protein tags to map the localization of neurotransmitter receptors within neural circuits in the Drosophila model organism. This work will provide crucial new insights into the...
This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $445,184 to Trustees of Boston University to explore strategies for rescuing neurological deficits associated with NEXMIF gene haploinsufficiency in female patients. The research aims to investigate the feasibility of reactivating the NEXMIF gene through inhibition of X chromosome inactivation factors, and determine the subsequent effects...
This $274,218.64 Project Grant from the National Institutes of Health's National Institute of Neurological Disorders and Stroke to Brandeis University will support research into the mechanisms underlying exosome release from neurons. The grant aims to determine how exosomes are generated from the endosomal system in neurons and explore neuronal exosome and endosome biology in an animal model. The grantee will manipulate the ESCRT and MUNC13-4/RAB11 pathways to investigate endosomal dynamics...
This federal Project Grant award of $656,513.00, awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to identify germline modifiers of neurofibromatosis type 1 (NF1) tumors. The primary grantee, Childrens Hospital Medical Center, will work with a multidisciplinary team to expand the patient cohort with plexiform neurofibromas and/or optic...

This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, will fund research to investigate the role of the EIF4A2 gene in interneuron development using a zebrafish model system.

The $234,630 award to The General Hospital Corporation (Massachusetts General Hospital) will support the generation and characterization of EIF4A2 loss-of-function and gain-of-function zebrafish models, examination of EIF4A2's impact on interneuron progenitor cell generation and differentiation, and assessment of EIF4A2 function on GABA interneuron migration. The research aims to identify targets for future investigation of both rare EIF4A2-associated neurodevelopmental disorders and more common conditions involving interneuron dysfunction. The project will be conducted from August 2024 through July 2029 and will involve collaborations with expert mentors from Boston Children's Hospital and other institutions.

Generated 7/8/25, 1:56 PM